Read article – Brayson Pawelczyk, MED ’24, is featured in an article on how members of Bucknell’s Class of 2020 transitioned from college life to graduate programs and other endeavors. He discusses how his days are filled with lectures, anatomy labs, team-based learning classes, case-based learning classes, and problem-based learning sessions. The article mentions that Pawelczyk is a medical student at the Geisel School of Medicine.
Articles by: Geisel Communications
Novel NSAID-Triptan Drug Effectively Relieves Migraine Pain – Medscape
Read article – Stewart Tepper, professor of neurology and study investigator, is quoted about a novel formulation containing meloxicam and rizatriptan, which provides effective pain relief for patients with migraines. “Rizatriptan’s primary mechanism is peripheral, and NSAIDs have both peripheral and central benefit,” said Tepper.
Selective Second Opinions May Lead to Better Accuracy, Less Cost in Melanocytic Lesions – Healio
Read article – Continued coverage of research co-authored by Anna N.A. Tosteson, interim director and professor of The Dartmouth Institute, and professor of medicine. Tosteson’s research found that selective second opinions could increase diagnostic accuracy and lower costs for patients being tested for skin cancers.
Gov. Scott Lifts All Remaining COVID-19 Restrictions in Vermont – VPR
Read article – Peter Wright, professor of pediatrics, is quoted in an article reporting that Vermont is lifting remaining COVID-19 pandemic restrictions. Asked for advice on what parents should do if their children aren’t old enough to get vaccinated, Wright said, “It just becomes a matter of your own assessment of the risk you want to take for your child … You’re really trying to think about the whole umbrella you’re under.”
Second-Opinion Strategy Analyzed for Cutaneous Melanocytic Lesions – HealthDay News
Read article – Research co-authored by Anna N.A. Tosteson, interim director and professor of The Dartmouth Institute, and professor of medicine, finds that second opinions may increase diagnostic accuracy and lower costs among patients undergoing skin biopsy for cutaneous melanocytic lesions.
Study Shows How Cowpea Mosaic Plant Virus Stimulates the Immune System Against Cancer – News Medical
Read article – A study co-authored by Steven N. Fiering, professor of microbiology and immunology, and researcher at Norris Cotton Cancer Center, finds that cowpea mosaic plant virus (CPMV) stimulates the immune system to attack and often eliminate a cancerous tumor. “The recognition of CPMV by toll-like receptors illustrates how these receptors are quite flexible and recognize many more molecular patterns than immunologists previously knew,” said Fiering.
DIY Nerve Stimulation Device ‘Highly Effective’ for Migraine Pain – Medscape
Read article – Stewart Tepper, professor of neurology, is quoted about a noninvasive, self-administered neurostimulation device to treat migraine pain. “This multicenter, pivotal, regulatory, sham-controlled study provides evidence that self-administered, noninvasive, combined occipital and trigeminal neurostimulation is a safe and highly effective acute treatment for migraine,” said Tepper.
Joseph C. Anderson, MD: Adding mt-sDNA Tests to Colonoscopies – HCPLive
Read article – Continued coverage of a study led by Joseph Anderson, associate professor of medicine, which found that using both stool-based tests and colonoscopies for colorectal cancer screenings was more effective than colonoscopies alone.
Low-Value End-of-Life Care in Some Patients With Cancer – Medscape
Read article – Maxwell Thomas Vergo, associate professor of medicine, is quoted about a study examining end-of-life care for patients with metastatic cancer who belong to racial and ethnic minority groups or have Medicare or Medicaid coverage. Vergo said, “Most studies look at end-of-life care in the last 30 days of life, but they don’t really include what the last days or hours of life look like, which can be tremendously important.”
LGBTQ+ Chemists You Should Know About – Chemical & Engineering News
Read article – Ben Barres, MED ’79, the first openly transgender member of the National Academy of Sciences, is remembered as part of a list of trailblazing LGBTQ+ chemists from history. The article, which coincides with the celebration of Pride Month, reports that “his work changed the way we understand the cells’ interactions with neurons.”